Substance / Medication

Ketorolac tromethamine

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

53 trials linked to this intervention

53
Total Trials
5
Recruiting
26
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effect of ketorolac tromethamine on pain management in patients with condyloma acuminata treated with 5-aminolevulinic acid photodynamic therapy.
Chen Xiaomeng, Liu Chang, Cao Shuanglin et al. · Photodiagnosis Photodyn Ther · 2025
PMID: 40409692RCT
A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers.
Pergolizzi Joseph V, Batra Amanjot, Schmidt William K · Adv Ther · 2024
PMID: 38070041RCT
The effect of topical ketorolac tromethamine on macular thickening after phacoemulsification in diabetic patients.
Mohammad-Rabei Hossein, Sabbaghi Hamideh, Emamverdi Mehdi et al. · BMC Ophthalmol · 2023
PMID: 37452330RCTFull text (PMC)
Pre-Emptive Topical Ketorolac Tromethamine 0.5% for Panretinal Photocoagulation.
Chewa Raja Joanne Shalini, Singh Sujaya, Ismail Fazliana · J Ocul Pharmacol Ther · 2021
PMID: 33794664RCT
In vitro anti-LPS dose determination of ketorolac tromethamine and in vivo safety of repeated dosing in healthy horses.
Bianco A W, Moore G E, Cooper B R et al. · J Vet Pharmacol Ther · 2018
PMID: 28600856RCT
Pharmacokinetics of ketorolac tromethamine in horses after intravenous, intramuscular, and oral single-dose administration.
Bianco A W, Constable P D, Cooper B R et al. · J Vet Pharmacol Ther · 2016
PMID: 26416348RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ketorolac trometamol (substance)
SNOMED CT
108513001
UMLS CUI
C0064326

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
53
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.